
Vishal Bhatnagar, MD
@vishalbmd
Associate Director for Patient Outcomes, Oncology Center of Excellence. FDA. Interested in MM and patient focused drug development. Opinions/tweets are my own
ID: 935170815577948166
27-11-2017 15:37:51
40 Tweet
258 Followers
123 Following



Why timing really matters in #pro assessment. Bellinda King-Kallimanis describes how we may miss important side effects if we assess #PROs day 1 of treatment cycle -are frequent brief assessments the way forward? #OCEOutcomes20 Paul Kluetz Vishal Bhatnagar, MD FDA Oncology CPROR

Happening now: FDA Oncology ASCO COA-CCT workshop Session 2, moderated by Bellinda King-Kallimanis - and important discussion about PRO assessment frequency #OCEOutcomes20

Folks you can't ask the right question at the wrong time! Timing of #PRO measurements must adapt as #cancer treatments (esp. their mechanisms, targets, etc) evolve!! FDA Oncology's Sundeep Agrawal tackles the timing challenge at ASCO FDA Oncology #OCEOutcomes20!



Patient-reported overall side effect bother is key to assessing tolerability. Listen to Paul Kluetz moderate a discussion w/ Laura Fernandes Gita Thanarajasingam Janet Freeman-Daily Sandra Spivey Preeti Narayan, MD, Dr Sandra Mitchell and Dr David Cella. Tune in now! #OCEOutcomes20






Exciting areas for meaningful #PFDD research! #PROs #RareDisease FDA Oncology

Excited for this workshop, focused on better characterizing patient-reported physical function! FDA Oncology



Listen in to two fantastic sessions moderated by FDA Oncology deputy director Paul Kluetz!

Mark your calendar and register for the FDA 7th Annual Clinical Outcome Assessment in Cancer Clinical Trials Workshop focused on patient-reported outcomes in open-label trials. June 29, 2022, 10am-3pm ET #OCEOutcomes22 with Paul Kluetz Vishal Bhatnagar, MD Erica Horodniceanu fda.gov/news-events/fd…


FDA Annual Clinical Outcome Assessment in Cancer Clinical Trials Workshop. June 29, 2022. Agenda and session panelist biographies now posted. Click to view full event details. #OCEOutcomes22 with Paul Kluetz Vishal Bhatnagar, MD Erica Horodniceanu bit.ly/39WunoN


Today's the day for FDA's 7th Annual Clinical Outcome Assessment in Cancer Clinical Trials Workshop on patient-reported outcomes in open-label trials! 6/29/22 - 10am-3pm ET #OCEOutcomes22 with Paul Kluetz Vishal Bhatnagar, MD #patientreportedoutcomes bit.ly/39WunoN
